AC8 0.00% 4.0¢ auscann group holdings ltd

AC8 Moving Forward - 2024, page-208

  1. 45 Posts.
    lightbulb Created with Sketch. 1
    Any news regarding commercializing cpat-h dermacann etc. I believe the medical aspect partnership will be most disruptive and profitable. Especially in the medical fields. And our benefit.. we need something big to allow momentum in the markets and vision for the ecosystem.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.